The Neuropharmacology and Pain Research Group at the Universitat de Barcelona (UB) and the Institut d"Investigació Biomèdica de Bellvitge (IDIBELL) was created in 2008 with the support of the Generalitat de Catalunya (SGR).
The research conducted in our group is mainly focused on seeking new pharmacological strategies to reach an effective management of neurological, neuropsychiatric and pain diseases. Our aim consists of providing a deep mechanistic understanding of neurotransmitter receptors functioning which may help to design combined therapies or oligomer-tailored drugs in the near future. In addition, our interests include the development and implementation of novel biotechnological methodologies (e.g. fluorescence based biosensors, optopharmacology, etc.) that may eventually evolve into new tools for both the study and diagnostic of diseases.
Finally, our main goal is the translation of our results from the bench to the bedside and to clinical practice. Accordingly, to translate basic scientific findings into therapeutic interventions for patients we are also involved in clinical pharmacology studies, specially pharmacoepidemiological studies and clinical trials.